Pharmaceutical

(Amendments) Amendments to “Non-consolidated Summary of Financial Results for the Fiscal Year Ended March 31, 2026”

(Amendments) Amendments to “Non-consolidated Summary of Financial Results for the Fiscal Year Ended March 31, 2026”

articlePerseus Proteomics, Inc.June 21, 20264/news/amendments-amendments-to-non-consolidated-summary-of-financial-results-for-the-fiscal-year-ended-march-31-2026
(Amendments) Amendments to “Non-consolidated Summary of Financial Results for the Fiscal Year Ended March 31, 2026”

About this update from Perseus Proteomics, Inc.

Perseus Proteomics, Inc. (4882) Press ReleaseView Attachment

View stock analysis, news, and events for Perseus Proteomics, Inc.